Trademark: 88879919
Word
BONCEBEK
Status
Pending
Status Code
734
Status Date
Friday, April 5, 2024
Serial Number
88879919
Mark Type
4000
Filing Date
Monday, April 20, 2020
Published for Opposition
Tuesday, September 14, 2021

Trademark Owner History
Celgene Corporation - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals preparations, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, and cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical use and clinical medical use

Trademark Events
Apr 6, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2024
Sou Teas Extension Received
Apr 5, 2024
Sou Extension 5 Granted
Apr 5, 2024
Sou Extension 5 Filed
Apr 5, 2024
Sou Teas Extension Received
Oct 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 12, 2023
Sou Extension 4 Granted
Oct 12, 2023
Sou Extension 4 Filed
Oct 12, 2023
Sou Teas Extension Received
Apr 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 26, 2023
Sou Extension 3 Granted
Apr 26, 2023
Sou Extension 3 Filed
Apr 26, 2023
Sou Teas Extension Received
Nov 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2022
Sou Extension 2 Granted
Nov 2, 2022
Sou Extension 2 Filed
Nov 2, 2022
Sou Teas Extension Received
Apr 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 27, 2022
Sou Extension 1 Granted
Apr 27, 2022
Sou Extension 1 Filed
Apr 27, 2022
Sou Teas Extension Received
Nov 9, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Published For Opposition
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 10, 2021
Approved For Pub - Principal Register
Jul 23, 2021
Teas/Email Correspondence Entered
Jul 23, 2021
Correspondence Received In Law Office
Jul 23, 2021
Teas Request For Reconsideration Received
Jan 26, 2021
Notification Of Final Refusal Emailed
Jan 26, 2021
Final Refusal E-Mailed
Jan 26, 2021
Final Refusal Written
Jan 12, 2021
Teas/Email Correspondence Entered
Jan 11, 2021
Correspondence Received In Law Office
Jan 11, 2021
Teas Response To Office Action Received
Jul 14, 2020
Notification Of Non-Final Action E-Mailed
Jul 14, 2020
Non-Final Action E-Mailed
Jul 14, 2020
Non-Final Action Written
Jul 11, 2020
Assigned To Examiner
Apr 29, 2020
New Application Office Supplied Data Entered
Apr 23, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24